{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:22:41Z","timestamp":1769606561175,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>Electrolyte abnormalities are hallmark metabolic disturbances during the treatment of acute lymphoblastic leukemia (ALL). Hyponatremia is an ominous laboratory sign in the setting of neoplasia. We analyzed the incidence, risk factors, associations, specific interventions and outcomes of severe hyponatremia in a single-center series of children with ALL. The incidence of severe hyponatremia, defined as serum sodium levels below 130 mmol\/L on at least 2 of 3 consecutive days, was 11.9%. History of hyponatremia episode is associated with neurologic complications (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.023) and the presence of overt central nervous system leukemia (CNS3) at diagnosis (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.005). Most observed hyponatremia episodes resolved relatively quickly, rarely requiring specific treatment. All but 1 hyponatremia episodes occurred in the induction or reinduction phases, but none before the administration of cytotoxic drugs, pointing to the role of therapy complications rather than leukemia per se. Most patients received vincristine shortly before hyponatremia onset, and vincristine has been previously strongly implicated in hyponatremia. We also suggest a role for imatinib. Although every patient with severe hyponatremia requires swift and thorough diagnostics a serious sequelae in the setting of pediatric ALL is rare. Hyponatremia association with neurotoxicity likely points to vincristine hypersensitivity in the subgroup of patients with both complications.<\/jats:p>","DOI":"10.1097\/mph.0000000000000758","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T03:44:34Z","timestamp":1483674274000},"page":"e54-e58","source":"Crossref","is-referenced-by-count":19,"title":["Severe Hyponatremia in a Single-Center Series of 84 Homogenously Treated Children With Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"39","author":[{"given":"Szymon","family":"Janczar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Zalewska-Szewczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Mlynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08880019509029545","article-title":"Clinical versus laboratory tumor lysis syndrome in children with acute leukemia","volume":"12","author":"Kedar","year":"1995","journal-title":"Pediatr Hematol Oncol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<201::AID-AJH1>3.0.CO;2-1","article-title":"Acid-base and electrolyte abnormalities in patients with acute leukemia","volume":"62","author":"Milionis","year":"1999","journal-title":"Am J Hematol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00520-015-2683-z","article-title":"Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients","volume":"23","author":"Berardi","year":"2015","journal-title":"Support Care Cancer"},{"issue":"pt 1","key":"R4-20230918","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1158\/1078-0432.CCR-05-1536","article-title":"A metabolic study of patients with lung cancer and hyponatremia of malignancy","volume":"12","author":"Chute","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1440-1754.2005.00760.x","article-title":"Hyponatraemia and seizures in oncology patients associated with hypotonic intravenous fluids","volume":"41","author":"Duke","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3121\/cmr.2007.762","article-title":"Tumor-related hyponatremia","volume":"5","author":"Onitilo","year":"2007","journal-title":"Clin Med Res"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF03346668","article-title":"Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"33","author":"Peri","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/08880019509029586","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"12","author":"Abe","year":"1995","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.bmt.1704688","article-title":"Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation","volume":"34","author":"Kobayashi","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPH.0000000000000478","article-title":"Analysis of risk factors for hyponatremia during or following chemotherapy in children with cancer: a hospital-based, retrospective cohort study","volume":"38","author":"Kishimoto","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"suppl 1","key":"R11-20230918","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0002-9343(71)90244-0","article-title":"Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy","volume":"51","author":"Cutting","year":"1971","journal-title":"Am J Med"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archpedi.1966.02090120124015","article-title":"Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion","volume":"112","author":"Fine","year":"1966","journal-title":"Am J Dis Child"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1651-2227.2001.tb03257.x","article-title":"Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies","volume":"90","author":"Kamaluddin","year":"2001","journal-title":"Acta Paediatr"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/pbc.22442","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone as a leading cause of hyponatremia in children who underwent chemotherapy or stem cell transplantation","volume":"54","author":"Lim","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1097-0142(196901)23:1<122::AID-CNCR2820230114>3.0.CO;2-E","article-title":"Vincristine neurotoxicity with hyponatremia","volume":"23","author":"Slater","year":"1969","journal-title":"Cancer"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases","volume":"55","author":"Moriyama","year":"2012","journal-title":"Mycoses"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/088800101753328529","article-title":"Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature","volume":"18","author":"Sathiapalan","year":"2001","journal-title":"Pediatr Hematol Oncol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1345\/aph.1L410","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone associated with imatinib","volume":"42","author":"Liapis","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0609.1997.tb00950.x","article-title":"Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukaemia","volume":"58","author":"Hagberg","year":"1997","journal-title":"Eur J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:51:43Z","timestamp":1695016303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201703000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000758","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}